1. Home
  2. OCSL vs RZLT Comparison

OCSL vs RZLT Comparison

Compare OCSL & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • RZLT
  • Stock Information
  • Founded
  • OCSL 2007
  • RZLT 2010
  • Country
  • OCSL United States
  • RZLT United States
  • Employees
  • OCSL N/A
  • RZLT N/A
  • Industry
  • OCSL Finance: Consumer Services
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCSL Finance
  • RZLT Health Care
  • Exchange
  • OCSL Nasdaq
  • RZLT Nasdaq
  • Market Cap
  • OCSL 1.1B
  • RZLT 819.3M
  • IPO Year
  • OCSL 2008
  • RZLT N/A
  • Fundamental
  • Price
  • OCSL $13.68
  • RZLT $8.90
  • Analyst Decision
  • OCSL Hold
  • RZLT Strong Buy
  • Analyst Count
  • OCSL 6
  • RZLT 7
  • Target Price
  • OCSL $15.20
  • RZLT $14.86
  • AVG Volume (30 Days)
  • OCSL 891.5K
  • RZLT 1.4M
  • Earning Date
  • OCSL 11-18-2025
  • RZLT 11-07-2025
  • Dividend Yield
  • OCSL 11.56%
  • RZLT N/A
  • EPS Growth
  • OCSL N/A
  • RZLT N/A
  • EPS
  • OCSL 0.55
  • RZLT N/A
  • Revenue
  • OCSL $334,099,000.00
  • RZLT N/A
  • Revenue This Year
  • OCSL N/A
  • RZLT N/A
  • Revenue Next Year
  • OCSL N/A
  • RZLT N/A
  • P/E Ratio
  • OCSL $25.32
  • RZLT N/A
  • Revenue Growth
  • OCSL N/A
  • RZLT N/A
  • 52 Week Low
  • OCSL $12.44
  • RZLT $2.22
  • 52 Week High
  • OCSL $16.53
  • RZLT $10.04
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 53.02
  • RZLT 49.63
  • Support Level
  • OCSL $13.71
  • RZLT $9.00
  • Resistance Level
  • OCSL $14.05
  • RZLT $10.03
  • Average True Range (ATR)
  • OCSL 0.26
  • RZLT 0.54
  • MACD
  • OCSL 0.03
  • RZLT -0.06
  • Stochastic Oscillator
  • OCSL 61.35
  • RZLT 27.68

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: